SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-001958
Filing Date
2024-01-10
Accepted
2024-01-10 16:42:14
Documents
15
Period of Report
2024-01-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 1134605
2 ex99-1.htm EX-99.1 14520
3 annex-a_001.jpg GRAPHIC 2329
  Complete submission text file 0001493152-24-001958.txt   1482978

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE tenku-20240110.xsd EX-101.SCH 4090
5 XBRL DEFINITION FILE tenku-20240110_def.xml EX-101.DEF 27176
6 XBRL LABEL FILE tenku-20240110_lab.xml EX-101.LAB 37633
7 XBRL PRESENTATION FILE tenku-20240110_pre.xml EX-101.PRE 25796
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6280
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017 (347) 627-0058
TenX Keane Acquisition (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41534 | Film No.: 24527054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)